RxDoctor Payments Data

Mark Logan, MD

Otolaryngology · Evansville, INNPI 1720077407

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.1% of the total.

$3,166in general payments, 2019–2025

Across 104 payments — averaging $30.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$794
  • Sanofi$731
  • Inspire Medical Systems, Inc.$377
  • Acclarent, Inc$289
  • Stryker$281
  • Intersect ENT, Inc.$134
  • plus $559 from 13 others

What the payments were for

  • Food & beverage$3,166100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,166 in reported general payments places this provider in the 70th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$191,275
Medicare patients
857
Services billed
4,610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth54$5,338
Ipratropium Bromide57$1,644
Azelastine Hcl22$1,360
Montelukast Sodium146$1,119
Ofloxacin43$565
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$465
Dexamethasone Sodium Phosphate12$443
Levothyroxine Sodium39$296
Ciprofloxacin Hcl22$283
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid60$219
Methylprednisolone28$186
CefuroximeCefuroxime Axetil15$186
Fluticasone Propionate16$164
Amoxicillin25$67
Hydrochlorothiazide12$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →